Advances in Clinical and Experimental Medicine

Adv Clin Exp Med
Impact Factor (IF) – 1.514
Index Copernicus (ICV 2018) – 157.72
MNiSW – 40
Average rejection rate – 84.38%
ISSN 1899–5276 (print)
ISSN 2451-2680 (online)
Periodicity – monthly

Download PDF

Advances in Clinical and Experimental Medicine

2016, vol. 25, nr 3, May-June, p. 561–568

doi: 10.17219/acem/33847

Publication type: review article

Language: English

Download citation:

  • BIBTEX (JabRef, Mendeley)
  • RIS (Papers, Reference Manager, RefWorks, Zotero)

Creative Commons BY-NC-ND 3.0 Open Access

B-Group Vitamins: Chemoprevention?

Beata M. Gruber1,A,B,C,D,E,F

1 Department of Biochemistry and Biopharmaceuticals, The National Medicines Institute, Warszawa, Poland


The importance of vitamins in the prevention of cancer has attracted the attention of consumers, nutritionists and scientists for decades. The mechanisms of carcinogenesis, extended in the context of the function of vitamins, i.e. regulation of and participation in metabolic processes in the cell, suggest a substantial impact of these compounds on the initial stages of carcinogenesis. One-carbon metabolism involving folic acid, vitamins B2, B6 and B12, and folate metabolism doesn’t only generate methyl groups, thus determining epigenetic processes, modifications of the genome and carcinogenesis. It also provides the compounds involved in the DNA synthesis and repair processes, especially the synthesis of purines and pyrimidines and the conversion of dUMP (2-deoxyuridine monophosphate) to dTMP (2-deoxythymidine monophosphate). In light of these pathways, folate, together with vitamins B2, B6 and B12, became a subject of interest as compounds whose deficit or surplus can potentially have an impact on the processes of carcinogenesis. Literature reports, however, do not fully confirm that the influence on the synthesis of nucleotides is connected with the inhibition of carcinogenesis. The impact of individual vitamins involved in one-carbon metabolism on carcinogenesis and their role in the prevention of these conditions depend on the type of cancer and the dose administered. Nevertheless, the research conducted makes it possible to conclude a considerable and probably long-underestimated role of these compounds in the prevention of serious, difficult to treat or incurable diseases.

Key words

group-B vitamins, one-carbon metabolism, folic acid

References (39)

  1. Van Popel G, van den Berg H: Vitamins and cancer. Cancer Lett 1997, 114, 195–202.
  2. Kozłowska J, Łaczmańska I: Niestabilność genetyczna – jej znaczenie w procesie powstawania nowotworów oraz diagnostyka laboratoryjna. J Oncol 2010, 60, 548–553.
  3. Gruber BM: Epigenetyka a etiologia chorób neurodegeneracyjnych. Postepy Hig Med Dosw 2011, 65, 542–551.
  4. Czeczot H: Kwas foliowy w fizjologii i patologii. Postepy Hig Med Dosw 2008, 62, 405–419.
  5. Figueiredo JC, Levine AJ, Grau MV, Barry E, Ueland PM, Ahnen DJ, Byers T, Bresalier RS, Summers RW, Bond J, McKeown-Eyssen G, Handler RS, Haile RW, Baron JA: Colorectal adenomas in a randomized folate trial: The role of baseline dietary and circulating folate levels. Cancer Epidemiol Biomarkers Prev 2008, 17, 2625–2631.
  6. Magnucki J, Sikora J, Machalski T, Kobielska L, Partyka R, Białas A: Czy hiperhomocysteinemia może stanowić przyczynę nawracających poronień? Ann Acad Med Siles 2009, 63, 84–92.
  7. Choi S-W, Mason JB: Folate and carcinogenesis: An integrated scheme. J Nutr 2000, 130, 129–132.
  8. Mason JB: Folate consumption and cancer risk: A confirmation and some reassurance, but we’re not out of the woods quite yet. Am J Clin Nutr 2011, 94, 965–966.
  9. Smith D, Kim Y-I, Refsum H: Is folic acid good for everyone? Am J Clin Nutr 2008, 87, 517–533.
  10. Tomaszewski JJ, Cummings JL, Parwani A, Dhir R, Mason JB, Nelson JB, Bacich DJ, O’Keefe DS: Increased cancer cell proliferation in prostate cancer patients with high levels of serum folate. Prostate 2011, 71, 1287–1293.
  11. Ly A, Lee H, Chen J, Sie KKY, Renlund R, Medline A, Sohn K-J, Croxford R, Thompson LU, Kim YI: Effect of maternal and postweaning folic acid supplementation on mammary tumor in the offspring. Cancer Res 2010, 71, 988–997.
  12. Kotsopoulos J, Medline A, Renlund R, Sohn KJ, Martin R, Hwang SW, Lu S, Archer MC, Kim YI: Effects of dietary folate on the development and progression of mammary tumors in rats. Carcinogenesis 2005, 26, 1603–1612.
  13. Chagas CE, Bassoli BK, de Souza CA, Deminice R, Jordão Júnior AA, Paiva SA, Dagli ML, Ong TP, Moreno FS: Folic acid supplementation during early hepatocarcinogenesis: Cellular and molecular effects. Int J Cancer 2011, 129, 2073–2082.
  14. Sauer J, Mason JB, Choi SW: Too much folate – a risk factor for cancer and cardiovascular disease? Curr Opin Clin Nutr Metab Care 2009, 12, 30–36.
  15. Crott JW, Choi S-W, Ordovas JM, Ditelberg JS, Mason JB: Effects of dietary folate and aging on gene expression in the colonic mucosa of rats: Implications for carcinogenesis. Carcinogenesis 2004, 25, 69–76.
  16. Xu X, Gammon MD, Wetmur JG, Rao M, Gaudet MM, Teitelbaum SL, Britton JA, Neugut AI, Santella RM, Chen J: A functional 19-base pair deletion polymorphism of dihydrofolate reductase (DHFR) and risk of breast cancer in multivitamin users. Am J Clin Nutr 2007, 85, 1098–10102.
  17. Inoue-Choi M, Ward MH, Cerhan JR, Weyer PJ, Anderson KE, Robien K: Interaction of nitrate and folate on the risk of breast cancer among postmenopausal women. Nutr Cancer 2012, 64, 685–694.
  18. Curtin K, Samowitz WS, Ulrich CM, Wolff RK, Herrick JS, Caan BJ, Slattery ML: Nutrients in folate-mediated, one-carbon metabolism and risk of rectal tumors in men and women. Nutr Cancer 2011, 63, 357–366.
  19. Collin SM, Metcalfe C, Zuccolo L, Lewis SJ, Chen L, Cox A, Davis M, Lane JA, Donovan J, Smith GD, Neal DE, Hamdy FC, Gudmundsson J, Sulem P, Rafnar T, Benediktsdottir KR, Eeles RA, Guy M, Kote-Jarai Z, UK Genetic Prostate Cancer Study Group, Morrison J, Al Olama AA, Stefansson K, Easton DF, Martin RM: Association of folate-pathway gene polymorphism with the risk of prostate cancer: A population-based nested case-control study, systematic review, and meta-analysis. Cancer Epidemiol Biomarkers Prev 2009, 18, 2528–2539.
  20. Eussen SJ, Vollset SE, Igland J, Meyer K, Fredriksen A, Ueland PM, Jenab M, Slimani N, Boffetta P, Overvad K, Tjønneland A, Olsen A, Clavel-Chapelon F, Boutron-Ruault MC, Morois S, Weikert C, Pischon T, Linseisen J, Kaaks R, Trichopoulou A, Zilis D, Katsoulis M, Palli D, Berrino F, Vineis P, Tumino R, Panico S, Peeters PH, Bueno-de-Mesquita HB, van Duijnhoven FJ, Gram IT, Skeie G, Lund E, González CA, Martínez C, Dorronsoro M, Ardanaz E, Navarro C, Rodríguez L, Van Guelpen B, Palmqvist R, Manjer J, Ericson U, Bingham S, Khaw KT, Norat T, Riboli E: Plasma folate, related genetic variants, and colorectal cancer risk in EPIC. Cancer Epidemiol Biomarkers Prev 2010, 19, 1328–1340.
  21. Maruti SS, Ulrich CM, White E: Folate and one-carbon metabolism nutrients from supplements and diet in relation to breast cancer risk. Am J Clin Nutr 2009, 89, 624–633.
  22. De Vogel S, van Engeland M, Lüchtenborg M, de Bruїne AP, Roemen GM, Lentjes MH, Goldbohm RA, van den Brandt PA, de Goeij AF, Weijenberg MP: Dietary folate and APC mutations in sporadic colorectal cancer. J Nutr 2006, 136, 3015–3021.
  23. Kim YI: Role of folate in colon cancer development and progression. J Nutr 2003, 133, 3731–3739.
  24. Mason JB: Folate, cancer risk, and the Greek god, Proteus: A tale of two chameleons. Nutr Rev 2009, 67, 206–212.
  25. Matsubara K, Matsumoto H, Mizushina Y, Lee JS, Kato N: Inhibitory effect of pyridoxal 5’-phosphate on endothelial cell proliferation, replicative DNA polymerase and DNA topoisomerase. Int J Mol Med 2003, 12, 51–55.
  26. Chou Y-Ch, Chu Ch-H, Wu M-H, Hsu G-Ch, Yang T, Chou W-Y, Huang H-P, Lee M-S, Yu Ch-P, Yu J-Ch, Sun Ch-A: Dietary intake of vitamin B6 and risk of breast cancer in Taiwanese women. J Epidemiol 2011, 21, 329–336.
  27. Zschäbitz S, Cheng T-Y D, Neuhouser ML, Zheng Y, Ray RM, Miller JW, Song X, Maneval DR, Beresford SAA, Lane D, Shikany JM, Ulrich CM: B vitamin intakes and incidence of colorectal cancer: Results from the Women’s Health Initiative Observational Study cohort. Am J Clin Nutr 2013, 97, 332–343.
  28. Pangrekar J, Krishnaswamy K, Jagadeesan V: Effects of riboflavin deficiency and riboflavin administration on carcinogen-DNA binding. Food Chem Toxicol 1993, 31, 745–750.
  29. Liu Z, Choi S-W, Crott JW, Smith DE, Mason JB: Multiple B-vitamin inadequacy amplifies alterations induced by folate depletion in p53 expression and its downstream effector MDM2. Int J Cancer 2008, 123, 519–525.
  30. Liu Z, Ciappio ED, Crott JW, Brooks RS, Nesvet J, Smith DE, Choi S-W, Mason JB: Combined inadequacies of multiple B vitamins amplify colonic Wnt signaling and promote intestinal tumorigenesis in BAT-LacZXApc1638N mice. FASEB J 2011, 25, 3136–3145.
  31. Hernandez BY, McDuffie K, Wilkens LR, Kamemoto L, Goodman MT: Diet and premalignant lesions of the cervix: Evidence of a protective role for folate, riboflavin, thiamin, and vitamin B12. Cancer Causes Control 2003, 14, 859–870.
  32. Rao PN, Levine E, Myers MO, Prakash V, Watson J, Stolier A, Kopicko JJ, Kissinger P, Raj SG, Raj MH: Elevation of serum riboflavin carrier protein in breast cancer. Cancer Epidemiol Biomarkers Prev 1999, 8, 985–990.
  33. Lajous M, Lazcano-Ponce E, Hernandez-Avila M: Folate, vitamin B6, and vitamin B12 intake and the risk of breast cancer among Mexican women. Cancer Epidemiol Biomarkers Prev 2006, 15, 443–448.
  34. Weiwei Z, Liping Ch, Dequan L: Association between dietary intake of folate, vitamin B6, B12 & MTHFR, MTR genotype and breast cancer risk. Pak J Med Sci 2014, 30, 106–110.
  35. Lu T, Xu Y, Monttinen ES, Kato N: Supplementing vitamin B6 to a low vitamin B6 diet exaggerates UVB-induced skin tumorigenesis in DMBA-treated hairless mice. J Nutr Sci Vitaminol 2008, 54, 262–265.
  36. Shimada D, Fukuda A, Kawaguchi H, Kato N, Yoshida H, Kanouchi H, Oka T: Effect of high dose of pyridoxine on mammary tumorigenesis. Nutr Cancer 2005, 53, 202–207.
  37. Collin SM, Metcalfe Ch, Refsum H, Lewis SJ, Zuccolo L, Smith GD, Chen L, Harris R, Davis M, Marsden G, Johnston C, Lane JA, Ebbing M, Bønaa KH, Nygård O, Ueland PM, Grau MV, Baron JA, Donovan J, Neal DE, Hamdy FC, Smith AD, Martin RM: Circulating folate, vitamin B12, homocysteine, vitamin B12 transport proteins and risk of prostate cancer: A case-control study, systematic review and meta-analysis. Cancer Epidemiol Biomrakers Prev 2010, 19, 1632–1642.
  38. Arendt JFB, Pedersen L, Nexo E, Sørensen HT: Elevated plasma vitamin B12 levels as a marker for cancer: A population-based cohort study. J Natl Cancer Inst 2013, 105, 1799–1805.
  39. Gruber BM: Suplementacja megadawkami witamin = megazdrowie? Farm Pol 2013, 69, 363–369.